Modulation of class II antigen expression
US5461033A · kind A · utility
21Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 1995 |
| Grant date | Oct 24, 1995 |
| Priority date | — |
| Expiry date | Feb 21, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The expression of Class II antigen expression by intestinal epithelial cells is modulated by administering to a mammal in need thereof an effective amount of TGF-.beta.2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.